Richard A. Waldron - Feb 21, 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Financial Officer
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Richard A. Waldron
Stock symbol
BCAB
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 08:18 PM
Previous filing
Feb 2, 2022
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Employee Stock Option (right to buy) Award $0 +115K $0.00 115K Feb 21, 2022 Common Stock 115K $6.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of four years, with 25% of the shares underlying the option vesting on February 21, 2023, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates.